- Service Name
CSL Behring
- Industry
Biotechnology, Biotherapeutics, Plasma Protein Therapy, Rare Diseases
- Main Value Proposition
CSL Behring is dedicated to saving lives by providing innovative therapies that address unmet medical needs for patients with serious and rare diseases.
- Description
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. The company focuses on innovative therapies for conditions in immunology, hematology, cardiovascular, metabolic, respiratory, and transplant therapeutic areas.
- Key Features
Broad range of plasma-derived and recombinant therapies; Innovative treatments for rare diseases; Commitment to patient-centric care; Extensive global reach with operations in over 100 countries
- Use Cases
CSL Behring's products are most valuable for treating bleeding disorders, immune deficiencies, chronic inflammatory conditions, and hereditary diseases.
- Competitive advantages
Leading position in the plasma protein biotherapeutics industry; Robust R&D capabilities with a focus on innovative therapies; Extensive global plasma collection network ensuring quality and supply
- Strengths
CSL Behring's strengths include its innovative product pipeline, commitment to patient care, and a strong emphasis on research and development to meet the needs of patients with rare diseases.
- Positioning
CSL Behring positions itself as a leader in biotherapeutics, focusing on innovative solutions for serious health conditions and a commitment to patient well-being.
- Audience
The target users include patients with rare and serious diseases, healthcare professionals, and researchers in the biotherapeutics field.
- CTA
Learn More About the Diseases We Treat
- Tags
Biotherapeutics
Rare Diseases
Patient Care
Innovation
- Tagline
Leading the Way on Serious & Rare Diseases
- Tone of Voice
Compassionate, Professional, Innovative
- Differentiation
CSL Behring stands out in the market due to its comprehensive approach to biotherapeutics, utilizing advanced technologies such as plasma fractionation and gene therapy, alongside a strong commitment to patient engagement and transparency.
- Brand Positioning
CSL Behring's brand identity is built on innovation, patient-centricity, and a promise to deliver life-saving therapies globally.
- Founded
1904-01-01